• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外受精方案中补充地屈孕酮的效果。

The effect of dydrogesterone supplementation in an IVF programme.

作者信息

Belaisch-Allart J, Testart J, Fries N, Forman R G, Frydman R

出版信息

Hum Reprod. 1987 Apr;2(3):183-5. doi: 10.1093/oxfordjournals.humrep.a136511.

DOI:10.1093/oxfordjournals.humrep.a136511
PMID:3597737
Abstract

Various treatments are given during the luteal phase by most IVF programmes, without any proof of their efficacy. We have performed a double-blind, randomized study with dydrogesterone (125 transfers) against placebo (133 transfers). The pregnancy rate was 21.6 versus 15.0% per transfer cycle with dydrogesterone or placebo, respectively. There was no significant difference between these figures, but taking into account the usual success rate in IVF programmes (15-20%) a difference of 5% would be significant only with two groups of 1500 subjects. This paper discusses the question of how we can come to a definite conclusion on the efficacy of hormonal supplementation during the luteal phase.

摘要

大多数试管婴儿项目在黄体期会采用各种治疗方法,但却没有任何证据证明其疗效。我们进行了一项双盲随机研究,比较了地屈孕酮(125例移植)与安慰剂(133例移植)的效果。每个移植周期中,使用地屈孕酮或安慰剂的妊娠率分别为21.6%和15.0%。这些数字之间没有显著差异,但考虑到试管婴儿项目通常的成功率(15%-20%),只有在两组各有1500名受试者的情况下,5%的差异才会具有显著性。本文讨论了如何就黄体期激素补充疗法的疗效得出明确结论这一问题。

相似文献

1
The effect of dydrogesterone supplementation in an IVF programme.在体外受精方案中补充地屈孕酮的效果。
Hum Reprod. 1987 Apr;2(3):183-5. doi: 10.1093/oxfordjournals.humrep.a136511.
2
A prospective randomized trial of human chorionic gonadotrophin or dydrogesterone support following in-vitro fertilization and embryo transfer.体外受精与胚胎移植后使用人绒毛膜促性腺激素或炔羟孕酮支持的前瞻性随机试验。
Hum Reprod. 1990 Apr;5(3):271-3. doi: 10.1093/oxfordjournals.humrep.a137087.
3
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.一项比较口服地屈孕酮与微粒化阴道孕酮在体外受精中黄体支持的疗效、安全性和耐受性的III期随机对照试验。
Hum Reprod. 2017 May 1;32(5):1019-1027. doi: 10.1093/humrep/dex023.
4
Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.口服地屈孕酮与阴道内微粒化孕酮作为辅助生殖技术(ART)周期黄体期支持的比较:一项随机研究的结果
J Steroid Biochem Mol Biol. 2005 Dec;97(5):416-20. doi: 10.1016/j.jsbmb.2005.08.012. Epub 2005 Oct 5.
5
[The comparison of efficiency of supplement of the second phase in the program IVF-ET by dydrogesterone and progesterone].[地屈孕酮与黄体酮在体外受精-胚胎移植(IVF-ET)方案中补充黄体期的疗效比较]
Ginekol Pol. 1999 Jan;70(1):8-12.
6
Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?口服地屈孕酮用于新鲜体外受精周期的黄体支持:新标准?
Fertil Steril. 2018 May;109(5):756-762. doi: 10.1016/j.fertnstert.2018.03.034.
7
A Phase III randomized controlled trial of oral dydrogesterone versus intravaginal progesterone gel for luteal phase support in fertilization (Lotus II): results from the Chinese mainland subpopulation.口服地屈孕酮与阴道用黄体酮凝胶用于黄体期支持的 III 期随机对照试验(荷花 II):来自中国大陆亚组的结果。
Gynecol Endocrinol. 2020 Feb;36(2):175-183. doi: 10.1080/09513590.2019.1645110. Epub 2019 Aug 9.
8
Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.口服地屈孕酮与阴道用黄体酮凝胶用于黄体期支持:随机对照试验
Eur J Obstet Gynecol Reprod Biol. 2015 Mar;186:49-53. doi: 10.1016/j.ejogrb.2014.11.002. Epub 2014 Nov 20.
9
A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles.地屈孕酮与微粒化孕酮用于体外受精(IVF)周期黄体期支持的比较研究。
Gynecol Endocrinol. 2016;32(3):213-7. doi: 10.3109/09513590.2015.1110136. Epub 2015 Nov 20.
10
New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.地屈孕酮在 IVF 促性腺激素预备周期中的新应用:一项纳入 516 个首次 IVF/ICSI 周期的随机对照试验。
Hum Reprod. 2018 Feb 1;33(2):229-237. doi: 10.1093/humrep/dex367.

引用本文的文献

1
Comparison of luteal support protocols in fresh IVF/ICSI cycles: a network meta-analysis.新鲜 IVF/ICSI 周期中黄体支持方案的比较:一项网状荟萃分析。
Sci Rep. 2024 Jun 24;14(1):14492. doi: 10.1038/s41598-024-64804-z.
2
Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny.早孕期地屈孕酮补充模拟 ART 患者黄体支持并未引起妊娠小鼠及其后代的主要生殖障碍。
Int J Mol Sci. 2021 May 20;22(10):5403. doi: 10.3390/ijms22105403.
3
Luteal phase support for assisted reproduction cycles.
辅助生殖周期的黄体期支持。
Cochrane Database Syst Rev. 2015 Jul 7;2015(7):CD009154. doi: 10.1002/14651858.CD009154.pub3.
4
Assessment of the luteal phase in stimulated and substituted cycles.刺激周期和替代周期中黄体期的评估。
Facts Views Vis Obgyn. 2009;1(1):30-46.
5
Luteal Phase Support in assisted reproductive technology treatment: focus on Endometrin(R) (progesterone) vaginal insert.辅助生殖技术治疗中的黄体支持:重点关注黄体酮阴道栓(Endometrin(R))。
Ther Clin Risk Manag. 2009 Aug;5(4):403-7. doi: 10.2147/tcrm.s4192. Epub 2009 Jun 4.